about
Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor modelAkt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromesTherapeutic Implications of Targeting AKT Signaling in MelanomaAMPK as a potential anticancer target - friend or foe?Disruptive chemicals, senescence and immortalityTargeting the RAS oncogene.Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidenceAkt1 enhances CA916798 expression through mTOR pathwayComputational insights into the inhibitory mechanism of human AKT1 by an orally active inhibitor, MK-2206BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signallingA melanoma molecular disease modelResveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor.Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells.Akt regulates TPP1 homodimerization and telomere protection.Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomasPossible protective effect of membrane lipid rafts against interleukin-1β-mediated anti-proliferative effect in INS-1 cells.Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and functionA novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells.Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cellsSignaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer.Targets for neural repair therapies after strokeAkt: a double-edged sword in cell proliferation and genome stability.The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models.Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis.Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells.Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA RepairInhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.S-Adenosylmethionine and methylthioadenosine inhibit β-catenin signaling by multiple mechanisms in liver and colon cancerMultiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer.Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR SignalingFear conditioning and extinction: emotional states encoded by distinct signaling pathways.Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy.AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cellThe Akt signaling pathway: an emerging therapeutic target in malignant melanoma.Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours
P2860
Q21133610-2971068D-3A93-4689-8B6F-9854BF4FCED3Q24319697-B20F6805-DD5C-477B-A5BA-09E1CB204483Q24320313-A63C8DD5-1040-40F8-8EBC-585B260C3D9FQ24631438-EB695A12-7272-41EB-AC3D-7254521EF236Q26829427-E0E976F2-57EF-44A8-8593-ED9CAC4E52AAQ27026235-4AF8F7F4-0C7D-40D4-9D64-E0B9EDA98910Q27687198-E1A0BFC6-3143-4502-8BB5-7B9E6936AA73Q28080599-9514F875-ADDA-4BCD-90D4-A48E327EB8CCQ28393187-F8ADA77C-27A6-4715-AED7-23B2C3ACBE63Q28487802-F40378BC-585E-4007-ACB9-D3FA38E7A10FQ28543899-89C20B44-7736-44CE-8B26-B4DAF8D41B5DQ28596448-422BB11D-62BC-4C09-9BFC-8E70D770BA8CQ28741507-F72EC85A-D1E1-4B88-8F0E-F25302B3254AQ30994649-EC063D2E-1AE4-42D6-B1CD-E5D12167D58DQ33713850-D97B0749-F6B4-4535-855A-83A41D59A804Q33732439-B4F69C0A-C876-4CA9-8100-B68F16E8F95AQ33846990-2E951448-5F3B-4279-B78E-A86A833B9B13Q33960501-D212E5DE-299A-4D99-868D-FD904D93CB9EQ34087816-FE4CDDA3-520F-43CA-9050-3D203C1274BDQ34099246-03E9DB01-3A06-42AE-A411-BF8721A29196Q34136150-6535C678-EBBA-4B17-A567-C2E4CBA3FDEFQ34170007-5AC4FCA2-7D77-40DA-BC2E-17C3E534D0B3Q34203585-BD1D48FB-F722-4235-A7FB-EEFA0346B941Q34204455-24CB42F8-B3B8-40B9-8B7E-3AF9A5A97BC5Q34223641-1FBD3255-B962-4269-8D25-D67548D97F42Q34229795-E36A6707-4798-4E78-A2BD-D398905010C6Q34388048-E08FB994-1CAF-49EC-B482-86CDDF1C9162Q34394189-E01CC796-A95D-4A32-8A91-ED9549B98645Q34430735-7778EBA3-025C-4FE5-8732-AAA89CCAF242Q34481443-11B6CF60-4612-4A94-9324-6BCD977EE939Q34541519-E583F96E-A400-4334-A92B-290643FF6B19Q34785481-AAAADF67-D068-493E-91E6-C86FBAF8D928Q34878940-3B875BA5-0F49-4BBE-A56A-FAF764D52210Q34978001-605BAD5E-0CBA-463F-B71B-49B92F9D550CQ35749913-23E022F7-61A1-4F7B-8798-6EBB3E5F02F1Q35791437-F771913D-5309-4E5D-9838-9AFB1366EB05Q35832894-BA89D6C6-4BED-4925-BDA0-A9A7723D2E7AQ35881962-380B0F15-B54A-487D-B875-DFE677A9BF97Q35911227-8E0C290B-368C-40D8-83CD-536CA8B37300Q35926007-59E79B13-1312-4CF5-940B-82181FD9A53A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The PKB/AKT pathway in cancer.
@en
The PKB/AKT pathway in cancer.
@nl
type
label
The PKB/AKT pathway in cancer.
@en
The PKB/AKT pathway in cancer.
@nl
prefLabel
The PKB/AKT pathway in cancer.
@en
The PKB/AKT pathway in cancer.
@nl
P1476
The PKB/AKT pathway in cancer.
@en
P356
10.2174/138161210789941865
P577
2010-01-01T00:00:00Z